OR WAIT null SECS
April 10, 2015
Aptar Pharma has partnered with Shanghai Sine Promod Pharmaceutical to develop and launch its new budesonide dry powder inhaler (DPI), which features Aptar Pharma’s user-friendly and cost-effective Twister DPI.
April 02, 2015
Emerging controlled-release technologies could lead to more effective therapies in the near future.
March 18, 2015
Sharon Johnson, senior vice president, Global Quality & Regulatory Affairs, will head the organization.
March 15, 2015
Taste may be subjective, but it is crucial to patient compliance, particularly for pediatric treatments.
March 02, 2015
While the skin offers an alternative route of administration for local and systemic drug delivery, developing semi-solid dosage forms can be a challenge.
February 23, 2015
Bristol-Myers Squibb announced that it reached an agreement to acquire Flexus Biosciences and has entered into a $309-million partnership with Rigel Pharmaceuticals.
February 20, 2015
Celgene announced that its drug, Revlimid, gained FDA approval for the treatment of newly diagnosed multiple myeloma.
February 04, 2015
Sanofi launched a rapidly absorbed, short-acting inhalable insulin in the US to help control type 1 and type 2 diabetes.
January 15, 2015
Catalent Pharma Solutions and Sanofi-Aventis R&D have entered into a collaboration to develop Sanofi’s proprietary antibodies using Catalent’s SMARTag antibody drug conjugate (ADC) platform.
January 12, 2015
Mexichem announced that it acquired the distribution and sale license for HFC-227ea/P from Du Pont.